Shares of Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) have been on a wild ride lately, with the stock down 17.94% over the past week and 24.23% over the past month as the broader space complex has sold off hard since SpaceX’s June 2026 IPO. Even after the pullback, RKLB is still up 19.57% year to date, 114.53% over the past 12 months, and a staggering 620.92% over five years.
At $81.45, the stock sits roughly 46% below its 52-week high of $151. This is the fourth drawdown of 40% or more on RKLB’s climb from under $4 per share. Most of the Street sits at a consensus target of $114.10. Then there is Morgan Stanley, which just lifted its bull-case target to $293, implying roughly 260% upside and towering 157% above consensus.
Reaching $293 by year-end 2026 would require Neutron’s on-time debut, Iridium accretion, and major Golden Dome awards converting to signed dollars.
Morgan Stanley’s $293 RKLB Prediction
Morgan Stanley reiterated its Overweight rating and $105 base case while pushing its bull case to $293, citing the growth runway of Rocket Lab’s space-systems division and the $8 billion Iridium acquisition announced June 29. The bank points to Q1 FY26 revenue of $200.35 million, up 63.5% year over year, a record $2.20 billion backlog, and a record 16-hour, 42-minute responsive launch on the U.S. Space Force VICTUS HAZE mission.
Key Drivers of RKLB Stock Performance
- Neutron and the defense flywheel. Neutron’s debut is targeted later in 2026, unlocking medium-lift revenue and layered awards like the Space Based Interceptor program under Golden Dome. Recurring defense contracts provide multi-decade cash flow visibility.
- Vertical integration through M&A. The Iridium deal, Geost’s $325 million sensor buy, Mynaric, and Motiv turn Rocket Lab into an end-to-end space platform with 2.5 million recurring subscribers, feeding durable long-term earnings power.
- Backlog visibility. A $2.20 billion backlog, 70-plus contracted missions, and the $816 million SDA contract give retirement investors rare multi-year revenue visibility in a high-growth name.
What Will It Take for RKLB to Reach $293?
With 629 million basic weighted average shares outstanding, a $293 price implies a market cap near $184.3 billion, up from the current $47.15 billion. Conditions required:
- A clean, on-time Neutron debut with reusable recovery.
- Iridium closing on schedule in mid-2027 with visible accretion.
- Major Golden Dome and SHIELD awards converting the $151 billion opportunity into signed dollars.
The primary risk is Neutron slippage colliding with continued net losses and equity dilution from ATM offerings. Even so, Morgan Stanley’s $293 call captures the optionality tied to Neutron, defense contracts, and the Iridium deal closing on schedule.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks